Literature DB >> 2892931

Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa.

E A Ewald1, D Griffin, W J McCune.   

Abstract

We evaluated angiograms of 26 patients with polyarteritis nodosa (PAN) as well as the associated clinical and laboratory features. All patients had visceral angiograms and either biopsy or angiographic proof of PAN. Severe disease was defined as central nervous system PAN, renal failure requiring dialysis, gangrene of fingers or toes, cardiomyopathy, bowel infarction, hepatic failure, or hepatic infarction. The presence of aneurysms was associated with severe hypertension, hepatitis B surface antigenemia and clinically severe disease. Angiography may therefore identify a subset of patients with more severe involvement and may be of value in management decisions.

Entities:  

Mesh:

Year:  1987        PMID: 2892931

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  An unusual complication of polyarteritis nodosa with massive retroperitoneal hemorrhage: a case report.

Authors:  Prashanth Peddi; Jagadeesh K Kalavakunta; Madhavi Annakula; John R Armstrong
Journal:  Int Arch Med       Date:  2010-11-11

2.  Spontaneous liver rupture as first sign of polyarteritis nodosa.

Authors:  Irene Gómez-Luque; Felipe Alconchel; Rubén Ciria; M Dolores Ayllón; Antonio Luque; Marina Sánchez; Pedro López-Cillero; Javier Briceño
Journal:  World J Hepatol       Date:  2016-11-18

Review 3.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

4.  Polyarteritis nodosa with perirenal hematoma due to the rupture of a renal artery aneurysm.

Authors:  Taro Miyagawa; Yasunori Iwata; Megumi Oshima; Hisayuki Ogura; Koichi Sato; Shiori Nakagawa; Yuta Yamamura; Shinji Kitajima; Tadashi Toyama; Akinori Hara; Satoshi Kokubo; Norihiko Sakai; Miho Shimizu; Kengo Furuichi; Takashi Wada
Journal:  CEN Case Rep       Date:  2020-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.